# | Title | Journal | Year | Citations |
---|
1 | Staging of brain pathology related to sporadic Parkinson’s disease | Neurobiology of Aging | 2003 | 8,567 |
2 | Inflammation and Alzheimer's disease | Neurobiology of Aging | 2000 | 4,069 |
3 | Staging of alzheimer's disease-related neurofibrillary changes | Neurobiology of Aging | 1995 | 1,943 |
4 | Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories | Neurobiology of Aging | 1997 | 1,469 |
5 | When does age-related cognitive decline begin? | Neurobiology of Aging | 2009 | 1,334 |
6 | New stereological methods for counting neurons | Neurobiology of Aging | 1993 | 897 |
7 | Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | Neurobiology of Aging | 2010 | 885 |
8 | Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Neurobiology of Aging | 2017 | 870 |
9 | Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease | Neurobiology of Aging | 1997 | 865 |
10 | Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment | Neurobiology of Aging | 2006 | 854 |
11 | Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease | Neurobiology of Aging | 2003 | 840 |
12 | Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease | Neurobiology of Aging | 2004 | 834 |
13 | Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease | Neurobiology of Aging | 1997 | 830 |
14 | Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ | Neurobiology of Aging | 2000 | 809 |
15 | Effects of age on tissues and regions of the cerebrum and cerebellum | Neurobiology of Aging | 2001 | 809 |
16 | Components of postural dyscontrol in the elderly: A review | Neurobiology of Aging | 1989 | 790 |
17 | The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | Neurobiology of Aging | 1991 | 781 |
18 | Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis | Neurobiology of Aging | 2009 | 766 |
19 | Age-related alterations in white matter microstructure measured by diffusion tensor imaging | Neurobiology of Aging | 2005 | 751 |
20 | Neuron numbers and dendritic extent in normal aging and Alzheimer's disease | Neurobiology of Aging | 1987 | 746 |
21 | What is physiologic complexity and how does it change with aging and disease? | Neurobiology of Aging | 2002 | 729 |
22 | Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases | Neurobiology of Aging | 2002 | 715 |
23 | The impact of age, weight and gender on BDNF levels in human platelets and plasma | Neurobiology of Aging | 2005 | 710 |
24 | Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Neurobiology of Aging | 1997 | 701 |
25 | Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease | Neurobiology of Aging | 1988 | 673 |
26 | Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling | Neurobiology of Aging | 2010 | 659 |
27 | Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease | Neurobiology of Aging | 1998 | 653 |
28 | Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI). 22The Reagan Institute Working Groups are planned and organized by Z. S. Khachaturian and T.S. Radebaugh; Fax: 301-879-2023; E-mail: zaven@idt.net. | Neurobiology of Aging | 1998 | 628 |
29 | Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1 | Neurobiology of Aging | 2002 | 628 |
30 | Vascular risk factors for Alzheimer’s disease: | Neurobiology of Aging | 2000 | 618 |
31 | Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume | Neurobiology of Aging | 2004 | 617 |
32 | Sex, stress and the hippocampus: allostasis, allostatic load and the aging process | Neurobiology of Aging | 2002 | 612 |
33 | PET imaging of amyloid deposition in patients with mild cognitive impairment | Neurobiology of Aging | 2008 | 611 |
34 | Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI | Neurobiology of Aging | 2011 | 611 |
35 | Body mass index is associated with biological CSF markers of core brain pathology in Alzheimer's disease | Neurobiology of Aging | 2012 | 589 |
36 | Measures of brain morphology and infarction in the framingham heart study: establishing what is normal | Neurobiology of Aging | 2005 | 588 |
37 | Identification of normal and pathological aging in prospectively studied nondemented elderly humans | Neurobiology of Aging | 1992 | 580 |
38 | Regionally specific loss of neurons in the aging human hippocampus | Neurobiology of Aging | 1993 | 572 |
39 | Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype | Neurobiology of Aging | 2006 | 560 |
40 | Glia and their cytokines in progression of neurodegeneration | Neurobiology of Aging | 2005 | 558 |
41 | Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease | Neurobiology of Aging | 2009 | 558 |
42 | Effects of age on volumes of cortex, white matter and subcortical structures | Neurobiology of Aging | 2005 | 552 |
43 | Hippocampus and entorhinal cortex in mild cognitive impairment and early AD | Neurobiology of Aging | 2004 | 539 |
44 | Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease | Neurobiology of Aging | 2003 | 530 |
45 | Common mechanisms of amyloid oligomer pathogenesis in degenerative disease | Neurobiology of Aging | 2006 | 513 |
46 | Hippocampal formation glucose metabolism and volume losses in MCI and AD | Neurobiology of Aging | 2001 | 511 |
47 | ApoE genotype accounts for the vast majority of AD risk and AD pathology | Neurobiology of Aging | 2004 | 509 |
48 | Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology | Neurobiology of Aging | 2001 | 501 |
49 | The role of cerebral ischemia in Alzheimer’s disease | Neurobiology of Aging | 2000 | 499 |
50 | Resting state fMRI in Alzheimer's disease: beyond the default mode network | Neurobiology of Aging | 2012 | 497 |